Weifeng Mi

469 total citations
13 papers, 211 citations indexed

About

Weifeng Mi is a scholar working on Psychiatry and Mental health, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Weifeng Mi has authored 13 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Cognitive Neuroscience. Recurrent topics in Weifeng Mi's work include Bipolar Disorder and Treatment (3 papers), Schizophrenia research and treatment (3 papers) and Diabetes Treatment and Management (2 papers). Weifeng Mi is often cited by papers focused on Bipolar Disorder and Treatment (3 papers), Schizophrenia research and treatment (3 papers) and Diabetes Treatment and Management (2 papers). Weifeng Mi collaborates with scholars based in China, Canada and Australia. Weifeng Mi's co-authors include Jingbo Xiao, Hongyan Zhang, Ying Shi, Lingzhi Li, Tianlan Lu, Su‐Xia Li, Luxian Lv, Dai Zhang, Lin Lü and Weihua Yue and has published in prestigious journals such as The Lancet, Journal of Affective Disorders and Schizophrenia Bulletin.

In The Last Decade

Weifeng Mi

12 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weifeng Mi China	8	84	44	42	34	29	13	211
Geoffrey A. Dunn United States	6	118 1.4×	38 0.9×	28 0.7×	18 0.5×	18 0.6×	11	290
Jean-François Costemale-Lacoste France	10	42 0.5×	46 1.0×	64 1.5×	40 1.2×	37 1.3×	17	287
Anna Wiste United States	9	151 1.8×	66 1.5×	28 0.7×	15 0.4×	14 0.5×	9	295
Hanna Kische Germany	11	28 0.3×	33 0.8×	72 1.7×	19 0.6×	65 2.2×	34	375
Jared Linthicum United States	8	62 0.7×	22 0.5×	39 0.9×	38 1.1×	30 1.0×	11	245
Barbara Scharnholz Germany	9	35 0.4×	35 0.8×	48 1.1×	13 0.4×	32 1.1×	14	269
Nicole E. MacKenzie Canada	7	121 1.4×	37 0.8×	42 1.0×	8 0.2×	28 1.0×	18	277
Benjamin Chadwick United States	7	46 0.5×	26 0.6×	56 1.3×	26 0.8×	8 0.3×	7	346
Sarika Thakur United States	6	27 0.3×	31 0.7×	49 1.2×	31 0.9×	12 0.4×	8	253
Kenya A. Costa-Dookhan Canada	9	193 2.3×	71 1.6×	38 0.9×	17 0.5×	16 0.6×	14	373

Countries citing papers authored by Weifeng Mi

Since Specialization

Citations

This map shows the geographic impact of Weifeng Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Mi more than expected).

Fields of papers citing papers by Weifeng Mi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Mi. The network helps show where Weifeng Mi may publish in the future.

Co-authorship network of co-authors of Weifeng Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Mi. A scholar is included among the top collaborators of Weifeng Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Mi. Weifeng Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mi, Weifeng, Lijun Xu, Jiyang Pan, et al.. (2025). A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder. Sleep Medicine. 139. 108722–108722.

Mi, Weifeng, et al.. (2024). Morinda officinalis oligosaccharides modulate the default-mode network homogeneity in major depressive disorder at rest. Psychiatry Research Neuroimaging. 343. 111847–111847. 1 indexed citations

Zhang, Yi, Shi‐Qiang Wang, Xin Wen, et al.. (2024). Causal role of immune cells in major depressive disorder and bipolar disorder: Mendelian randomization (MR) study. Journal of Affective Disorders. 361. 165–171. 8 indexed citations

Li, Zhe, Ziyi Li, Ke Wang, et al.. (2023). Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis. Psychiatry Research. 332. 115637–115637. 8 indexed citations

Chen, Jing, Wei Chen, Hongyan Zhang, et al.. (2022). Reliability and validity of the Chinese version of the Oxford Depression Questionnaire (ODQ-Chinese). Journal of Affective Disorders. 313. 278–282. 7 indexed citations

Mi, Weifeng, Fude Yang, Huafang Li, et al.. (2021). Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial. The International Journal of Neuropsychopharmacology. 25(3). 252–260. 16 indexed citations

Que, Jianyu, Le Shi, Jiajia Liu, et al.. (2019). Prevalence of suicidal thoughts and behaviours among medical professionals: a meta-analysis and systematic review. The Lancet. 394. S11–S11. 10 indexed citations

Sun, Hongqiang, Su‐Xia Li, Yan Zhang, et al.. (2015). Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients. Psychoneuroendocrinology. 64. 108–116. 38 indexed citations

Yu, Hao, Lifang Wang, Luxian Lv, et al.. (2015). Genome-Wide Association Study Suggested thePTPRDPolymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications. Schizophrenia Bulletin. 42(3). 814–823. 28 indexed citations

10.

Zhang, Hongyan, Weifeng Mi, Lingzhi Li, Ying Shi, & Jingbo Xiao. (2015). High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s Republic of China. Neuropsychiatric Disease and Treatment. 11. 1161–1161. 55 indexed citations

11.

Wang, Fang, Weifeng Mi, Wenbin Ma, et al.. (2015). A Pharmacogenomic Study Revealed an Association Between SLC6A4 and Risperidone-Induced Weight Gain in Chinese Han Population. Pharmacogenomics. 16(17). 1943–1949. 6 indexed citations

12.

Hu, Xiao, Jishui Zhang, Chao Jin, et al.. (2013). Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 43. 197–202. 32 indexed citations

13.

Ma, Yuanlin, et al.. (2012). Effect of Morinda officinalis how oligosaccharides on the regeneration and growth of hippocampal neurons. 21(22). 2623–2626. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact